Formycon And MS Pharma Add Ustekinumab To MENA Alliance

Follows Earlier Biosimilars Deals On Ranibizumab And Aflibercept

 
• By Dave Wallace

Formycon and MS Pharma have followed up on previous biosimilar collaborations in the MENA region with a fresh alliance on Stelara rival FYB202.

The partners have racked up a third collaboration (Shutterstock)

More from Deals

More from Products